« To Hold or Not to Hold? Periprocedural Management of Glucagon-like Peptide-1 Receptor‑based Agonists (GLP‑1ra) in Patients with Diabetes and Obesity » (2026) Canadian Diabetes & Endocrinology Today, 4(1), p. 26–34. doi:10.58931/cdet.2026.4152.